Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Hearts from illicit drug users safe to transplant | TEER & cardiogenic shock | New ASCVD guidelines
Friday, July 30, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Hearts from donors with a history of drug use are safe for transplant

"We thought that illicit drugs like cocaine or methamphetamine, which can lead to heart attacks, would prove to be dangerous,” one researcher said. "However, we were wrong."

READ MORE >
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
Share on Twitter Share on Facebook Share on Linkedin

Hearts from donors with a history of drug use are safe for transplant

Share on Twitter Share on Facebook Share on Linkedin
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
"We thought that illicit drugs like cocaine or methamphetamine, which can lead to heart attacks, would prove to be dangerous,” one researcher said. "However, we were wrong."
READ MORE >

Digital solution for heart failure gains FDA’s breakthrough device designation

The digital therapeutic helps patients follow recommended treatment guidelines by monitoring their health data, connecting them to healthcare providers and personalizing their treatment when necessary.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Digital solution for heart failure gains FDA’s breakthrough device designation

Share on Twitter Share on Facebook Share on Linkedin
The digital therapeutic helps patients follow recommended treatment guidelines by monitoring their health data, connecting them to healthcare providers and personalizing their treatment when necessary.
READ MORE >

TEER shows potential to boost outcomes for cardiogenic shock patients

Cardiogenic shock has been linked to a heightened risk of morbidity and mortality. TEER, it seems, may be able to help provide patients with some relief. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TEER shows potential to boost outcomes for cardiogenic shock patients

Share on Twitter Share on Facebook Share on Linkedin
Cardiogenic shock has been linked to a heightened risk of morbidity and mortality. TEER, it seems, may be able to help provide patients with some relief. 
READ MORE >

DOACs reduce stroke risk better than aspirin among high-risk ablation patients

Researchers presented the new data at Heart Rhythm 2021.

READ MORE >
Patient
Share on Twitter Share on Facebook Share on Linkedin

DOACs reduce stroke risk better than aspirin among high-risk ablation patients

Share on Twitter Share on Facebook Share on Linkedin
Patient
Researchers presented the new data at Heart Rhythm 2021.
READ MORE >

American College of Cardiology shares new guidance for treating ASCVD patients with elevated triglycerides

The guideline's authors set out to show that a multi-pronged approach is necessary in the treatment of high-risk ASCVD patients with elevated triglycerides.

READ MORE >
cholesterol.png
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology shares new guidance for treating ASCVD patients with elevated triglycerides

Share on Twitter Share on Facebook Share on Linkedin
cholesterol.png
The guideline's authors set out to show that a multi-pronged approach is necessary in the treatment of high-risk ASCVD patients with elevated triglycerides.
READ MORE >

Featured Articles

Medtronic gains FDA approval for AI models focused on cardiac monitoring

The advanced algorithms address two areas known for causing false ICM alerts: atrial fibrillation and asystole.

READ MORE >
Approved
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains FDA approval for AI models focused on cardiac monitoring

Share on Twitter Share on Facebook Share on Linkedin
Approved
The advanced algorithms address two areas known for causing false ICM alerts: atrial fibrillation and asystole.
READ MORE >

Quality intervention fails to boost outcomes for HFrEF patients

Researchers aimed to use a proven strategy to improve patient care, but their intervention did not make a substantial impact. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Quality intervention fails to boost outcomes for HFrEF patients

Share on Twitter Share on Facebook Share on Linkedin
Researchers aimed to use a proven strategy to improve patient care, but their intervention did not make a substantial impact. 
READ MORE >

How the body's own immune response is harming some COVID-19 patients

Needless platelet activity in the lungs may be one of the primary reasons clinicians are seeing inflammation and blood clotting in critically ill COVID-19 patients.

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

How the body's own immune response is harming some COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
Needless platelet activity in the lungs may be one of the primary reasons clinicians are seeing inflammation and blood clotting in critically ill COVID-19 patients.
READ MORE >

In Other News

AI software helps radiologists cut unnecessary chest CT scans by 30%

Patients also benefit by avoiding unneeded radiation exposure, while healthcare systems sidestep added medical costs.

READ MORE >
financial graph downturn drop dip
Share on Twitter Share on Facebook Share on Linkedin

AI software helps radiologists cut unnecessary chest CT scans by 30%

Share on Twitter Share on Facebook Share on Linkedin
financial graph downturn drop dip
Patients also benefit by avoiding unneeded radiation exposure, while healthcare systems sidestep added medical costs.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme